Moreover, more expression of OCT4 was observed in the gefitinib insensetive PC-9/GR cell compared with the gefitinib sensitive PC-9 cell, indicating that OCT4 is a possible tumorgenesis contributor in NSCLC. The gene discussed is POU5F1; the disease is non-small cell lung carcinoma.